Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Boulder biotech research company SomaLogic Inc. has raised $10 million in equity financing from unidentified investors. The funding was disclosed in new filing to the Securities & Exchange Commission. The company is researching diagnostic technologies capable to determining a person’s genetic predisposition for diseases — or, possibly, active illness before symptoms show — by analyzing a drop of a patient’s blood.
Help employers find you! Check out all the jobs and post your resume.
